1887

Abstract

The stability and structure of the products of recombination in a fowlpox virus (FPV) system using the thymidine kinase (TK) gene as the insertion site were examined. A 4.6 kb chimeric DNA fragment from the pUV1 expression vector, containing the bacterial gene and the vaccinia virus P7.5 promoter, was ligated into the I site of the FPV TK gene. The resulting vector, pFTKlacZb, was transfected into chicken embryo fibroblast cultures infected with FPV at an m.o.i. of 0.1. Recombinants were screened for the expression of β-galactosidase. Five recombinants were isolated and plaque-purified to 80 to 90% for expression of β-glucosidase. Serial cell culture passage of the recombinants led to the gradual reappearance of the non-recombinant parental phenotype. Southern hybridization analysis of RI fragments from all five recombinants indicated that a single cross-over homologous recombination had occurred between either the 5′ or the 3′ end fragments of the TK gene, generating unstable intermediate recombinants incorporating the entire pFTKlacZb vector. Secondary intermolecular or intramolecular recombination of intergenic repetitive sequences within the intermediate recombinants appears to have resulted in frequent regeneration of the parental genotype and an infrequent generation of more stable recombinants. A method was developed to select stable recombinants by passage of the intermediate recombinants in chicken embryo fibroblast cultures treated with 5-bromo-2′-deoxyuridine.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-72-11-2791
1991-11-01
2021-10-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/72/11/JV0720112791.html?itemId=/content/journal/jgv/10.1099/0022-1317-72-11-2791&mimeType=html&fmt=ahah

References

  1. Beisel C., Nazerian K. 1987; Construction of avian vaccine vectors from fowlpox virus: mapping and characterization of the FPV thymidine kinase gene. Proceedings of the VII International Congress of Virology p 283
    [Google Scholar]
  2. Belsham G. J., Brangwyn J. K., Ryan M. D., Abrams C. C., King A. M. Q. 1990; Intracellular expression and processing of foot-and-mouth disease virus capsid precursors using vaccinia virus vectors: influence of the L protease. Virology 176:524–530
    [Google Scholar]
  3. Boyle D. B., Coupar B. E. H. 1988; Construction of recombinant fowlpox viruses as vectors for poultry vaccines. Virus Research 10:343–356
    [Google Scholar]
  4. Boyle D. B., Coupar B. E. H., Gibbs A. J., Seigman L. J., Both G. W. 1987; Fowlpox virus thymidine kinase: nucleotide sequence and relationship to other thymidine kinases. Virology 156:355–365
    [Google Scholar]
  5. Chakrabarti S., Robert-Guroff M., Wong-Staal F., Gallo R. C., Moss B. 1986; Expression of the HTLV-III envelope gene by a recombinant vaccinia virus. Nature, London 320:535–537
    [Google Scholar]
  6. Dhawale S., Beisel C. E., Nazerian K. 1990; Transient expression assay for qualitative assessment of gene expression by fowlpox virus. Virus Genes 3:213–220
    [Google Scholar]
  7. Elango N., Prince G. A., Murphy B. R., Venkatesan S., Chanock R. M., Moss B. 1986; Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein. Proceedings of the National Academy of Sciences, U.S.A. 83:1906–1910
    [Google Scholar]
  8. Falkner F. G., Moss B. 1990; Transient dominant selection of recombinant vaccinia viruses. Journal of Virology 64:3108–3111
    [Google Scholar]
  9. Falkner F. G., Chakrabarti S., Moss B. 1987; pUVI: a new vaccinia virus insertion and expression vector. Nucleic Acids Research 15:7592
    [Google Scholar]
  10. Moss B., Smith G. L., Jerin J. L., Purcell R. H. 1984; Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature, London 311:67–69
    [Google Scholar]
  11. Nazerian K., Dhawale S., Payne W. S. 1989; Structural proteins of two different plaque-size phenotypes of fowlpox virus. Avian Diseases 33:458–465
    [Google Scholar]
  12. Paoletti E., Lipinska B. R., Samsonoff C., Mercer S., Panicali D. 1984; Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D. Proceedings of the National Academy of Sciences, U.S.A. 81:193–197
    [Google Scholar]
  13. Spehner D., Drillien R., Lecocq J. 1990; Construction of fowlpox virus vectors with intergenic insertions: expression of the beta-galactosidase and the measles virus fusion gene. Journal of Virology 64:527–533
    [Google Scholar]
  14. Spyropoulos D., Roberts B. E., Panicali D. L., Cohen L. K. 1988; Delineation of the viral products of recombination in vaccinia virus-infected cells. Journal of Virology 62:1046–1054
    [Google Scholar]
  15. Taylor J., Weinberg R., Kawaoka Y., Webster R., Paoletti E. 1988a; Protective immunity against avian influenza induced by a fowlpox virus recombinant. Vaccine 6:504–508
    [Google Scholar]
  16. Taylor J., Weinberg R., Languet B., Desmettre P., Paoletti E. 1988b; Recombinant fowlpox virus inducing protective immunity in non-avian species. Vaccine 6:497–503
    [Google Scholar]
  17. Taylor J., Edbasuer C., Rey-Senelonge A., Bouquet J. F., Norton E., Goebel S., Desmettre P., Paoletti E. 1990; Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens. Journal of Virology 64:1441–1450
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-72-11-2791
Loading
/content/journal/jgv/10.1099/0022-1317-72-11-2791
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error